The treatment of mice with the non-selective Panx1 blocker Probenecid reduced ATP release and slowed renal cyst development by improving epithelial transport across the cyst epithelium, thus demonstrating that Panx1 could be a new target for the treatment of ADPKD [14]. The gene discussed is PANX1; the disease is Renal cyst.